Acceleron Pharma to Present at Upcoming Investor Conferences in November

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, today announced it will participate in the following upcoming investor conferences.

A live audio webcast of the presentation at the 24th Annual Credit Suisse Healthcare Conference will be available on the “Events and Presentations” page in the Investors & Media section on the Company’s website (www.acceleronpharma.com). A replay of the webcast will also be available from Acceleron’s website.

About Acceleron

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair. The company is a leader in understanding the biology of the Transforming Growth Factor-Beta protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body, and in targeting these pathways to develop important new medicines. Acceleron has built a highly productive R&D platform that has generated innovative clinical and preclinical therapeutic candidates with novel mechanisms of action. These therapeutic candidates have the potential to significantly improve clinical outcomes for patients with cancer and rare diseases.

For more information, please visit www.acceleronpharma.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151102005272/en/

Acceleron Pharma Inc.
Todd James, 617-649-9393
Senior Director, Corporate Communications
or
Media:
Suda Communications LLC
Maureen L. Suda, 585-387-9248

Source: Acceleron Pharma

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• Knowledge Returns Alliance Expands AI-Enabled Financial Education Through PF System
• Takara FX Partners with Ana Botin's Botin Gold Analysis Team, Making AI Trading a Key Focus of Strategic Collaboration